Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	3,709	4,209	4,103	5,341	8,945	7,761
Market Cap Growth	-8.05%	2.60%	-23.18%	-40.29%	15.26%	78.41%
Enterprise Value	136	636	3,795	3,388	6,198	6,696
Last Close Price	16.90	19.18	17.35	21.48	33.25	27.35
PE Ratio	-	-	55.06	71.28	2.13	5.49
PS Ratio	13.99	15.88	11.72	7.13	0.85	2.74
PB Ratio	0.65	0.74	0.68	0.85	1.32	2.72
P/TBV Ratio	0.67	0.76	0.71	0.89	1.38	2.80
P/FCF Ratio	-	-	-	18.91	2.42	7.58
P/OCF Ratio	-	-	-	13.61	2.23	6.89
EV/Sales Ratio	0.51	2.40	10.84	4.52	0.59	2.37
EV/EBITDA Ratio	-	-	-	57.13	1.20	3.93
EV/EBIT Ratio	-	-	-	-	1.21	3.98
EV/FCF Ratio	-0.84	-	-	11.99	1.68	6.54
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.03	0.02
Debt / EBITDA Ratio	-	-	-	0.64	0.04	0.03
Debt / FCF Ratio	-	-	-	0.17	0.06	0.04
Net Debt / Equity Ratio	-0.65	-0.65	-0.21	-0.17	-0.65	-0.65
Net Debt / EBITDA Ratio	68.93	68.93	14.38	-18.37	-0.84	-1.08
Net Debt / FCF Ratio	23.24	23.24	4.76	-3.85	-1.18	-1.80
Asset Turnover	-	-	0.05	0.09	1.67	1.17
Inventory Turnover	-	-	2.06	1.60	14.70	3.52
Quick Ratio	-	-	4.32	2.42	3.10	4.84
Current Ratio	-	-	4.84	2.70	3.25	5.50
Return on Equity (ROE)	-1.28%	-1.28%	0.43%	1.06%	91.05%	72.97%
Return on Assets (ROA)	-	-	-1.31%	-0.05%	50.90%	43.43%
Return on Invested Capital (ROIC)	-5.33%	-3.15%	-2.41%	-0.09%	260.54%	206.48%
Return on Capital Employed (ROCE)	-	-	-2.40%	-0.10%	75.20%	58.60%
Earnings Yield	-0.44%	-0.39%	1.82%	1.40%	47.05%	18.21%
FCF Yield	-4.34%	-3.82%	-6.58%	5.29%	41.36%	13.19%
Dividend Yield	6.83%	-	7.09%	0.56%	10.50%	7.41%
Payout Ratio	-	-	63.59%	777.41%	13.08%	20.05%
Buyback Yield / Dilution	-4.13%	-4.13%	0.54%	1.22%	-8.61%	-1.43%
Total Shareholder Return	2.69%	-4.13%	7.63%	1.78%	1.89%	5.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.